The majority of patients may safely take glucagon-like peptide 1 receptor agonists (GLP-1 RAs) before elective surgery and ...
For patients with opioid use disorder (OUD) and alcohol use disorder (AUD), prescriptions of glucose-dependent insulinotropic polypeptide (GIP) and/or glucagon-like peptide-1 receptor agonists (GLP-1 ...
Recent studies have shown that pharmacological treatment with GLP-1-RA and dual GLP-1/glucose-dependent insulinotropic ...
However, there is little evidence to show that this is the case, despite the fact that GLP-1 RA use in the year before ...
Greatest increase in SGLT2 inhibitor use seen in subgroups with cardiovascular disease; greatest increase in GLP-1 RA for those with obesity ...
In a multisociety clinical practice guidance document, published online Oct. 29 in Surgery for Obesity and Related Diseases, ...
MedPage Today on MSN11d
ASA Advises No Longer Holding GLP-1 Agents Prior to Surgery for Most PatientsMost patients should not stop taking GLP-1 receptor agonists prior to elective surgery, according to updated guidance from ...
Greatest increase in SGLT2 inhibitor use seen in subgroups with cardiovascular disease; greatest increase in GLP-1 RA for those with obesity.
healthday on MSN9d
ACG: GLP-1 RAs Tied to Lower Risk for Early-Onset Colorectal CancerGlucagon-like peptide-1 receptor agonists (GLP-1 RAs) can decrease the risk for developing early-onset colorectal cance ...
The greatest increase in SGLT2 inhibitor prescribing occurred in T1D subgroups with cardiovascular disease, while those with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback